北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学医药卫生分析中心  > 期刊论文
学科主题: 公共卫生
题名:
Evaluation of In-111-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability
作者: Shi, Jiyun1,2; Zhou, Yang1; Chakraborty, Sudipta1; Kim, Young-Seung1; Jia, Bing2; Wang, Fan2; Liu, Shuang1
关键词: integrin alpha(v)beta(3) ; In-111-labeled cyclic RGD peptides ; tumor imaging
刊名: THERANOSTICS
发表日期: 2011
DOI: 10.7150/thno/v01p0322
卷: 1, 页:322-340
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, Research & Experimental
研究领域[WOS]: Research & Experimental Medicine
关键词[WOS]: INTEGRIN ALPHA(V)BETA(3) EXPRESSION ; GLIOMA INTEGRIN-ALPHA(V)BETA(3) EXPRESSION ; DRUG DEVELOPMENT ; BIODISTRIBUTION CHARACTERISTICS ; PEG(4) LINKERS ; BREAST-CANCER ; ANGIOGENESIS ; DIMER ; MICROPET ; PHARMACOKINETICS
英文摘要:

Purpose: The purpose of this study was to demonstrate the valence of cyclic RGD peptides, P-RGD (PEG(4)-c(RGDfK): PEG(4) = 15-amino-4,710,13-tetraoxapentadecanoic acid), P-RGD(2) (PEG(4)-E[c(RGDfK)](2), 2P-RGD(4) (E{PEG(4)-E[c(RGDfK)](2)}(2), 2P(4)G-RGD(4) (E{PEG(4)-E[G(3)-c(RGDfK)](2)}(2): G(3) = Gly-Gly-Gly) and 6P-RGD(4) (E{PEG(4)-E[PEG(4)-c(RGDfK)](2)}(2)) in binding to integrin alpha(v)beta(3), and to assess the impact of peptide and linker multiplicity on biodistribution properties, excretion kinetics and metabolic stability of their corresponding In-111 radiotracers.

Methods: Five new RGD peptide conjugates (DOTA-P-RGD (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid), DOTA-P-RGD(2), DOTA-2P-RGD(4), DOTA-2P4G-RGD(4), DOTA-6P-RGD(4)), and their In-111 complexes were prepared. The integrin alpha(v)beta(3) binding affinity of cyclic RGD conjugates were determined by a competitive displacement assay against I-125-c(RGDyK) bound to U87MG human glioma cells. Biodistribution, planar imaging and metabolism studies were performed in athymic nude mice bearing U87MG human glioma xenografts.

Results: The integrin alpha(v)beta(3) binding affinity of RGD conjugates follows the order of: DOTA-6P-RGD(4) (IC50 = 0.3 +/- 0.1 nM) similar to DOTA-2P4G-RGD(4) (IC50 = 0.2 +/- 0.1 nM) similar to DOTA-2P-RGD(4) (IC50 = 0.5 +/- 0.1 nM) > DOTA-3P-RGD(2) (DOTA-PEG(4)-E[PEG(4)-c(RGDfK)](2): IC50 = 1.5 +/- 0.2 nM) > DOTA-P-RGD(2) (IC50 = 5.0 +/- 1.0 nM) >> DOTA-P-RGD (IC50 = 44.3 +/- 3.5 nM) similar to c(RGDfK) (IC50 = 49.9 +/- 5.5 nM) >> DOTA-6P-RGK(4) (IC50 = 437 +/- 35 nM). The fact that DOTA-6P-RGK(4) had much lower integrin alpha(v)beta(3) binding affinity than DOTA-6P-RGD(4) suggests that the binding of DOTA-6P-RGD(4) to integrin alpha(v)beta(3) is RGD-specific. This conclusion is consistent with the lower tumor uptake for In-111(DOTA-6P-RGK(4)) than that for In-111(DOTA-6P-RGD(4)). It was also found that the G(3) and PEG(4) linkers between RGD motifs have a significant impact on the integrin alpha(v)beta(3)-targeting capability, biodistribution characteristics, excretion kinetics and metabolic stability of In-111-labeled cyclic RGD peptides.

Conclusion: On the basis of their integrin alpha(v)beta(3) binding affinity and tumor uptake of their corresponding In-111 radiotracers, it was conclude that 2P-RGD(4), 2P4G-RGD(4) and 6P-RGD(4) are most likely bivalent in binding to integrin alpha(v)beta(3), and extra RGD motifs might contribute to the long tumor retention times of In-111(DOTA-2P-RGD(4)), In-111(DOTA-2P4G-RGD(4)) and In-111(DOTA-6P-RGD(4)) than that of In-111(DOTA-3P-RGD3) at 72 h p.i. Among the In-111-labeled cyclic RGD tetramers evaluated in the glioma model, In-111(DOTA-2P4G-RGD(4)) has very high tumor uptake with the best tumor/kidney and tumor/liver ratios, suggesting that Y-90(DOTA-2P4G-RGD(4)) and Lu-177(DOTA-2P4G-RGD(4)) might have the potential for targeted radiotherapy of integrin alpha(v)beta(3)-positive tumors.

语种: 英语
所属项目编号: R01 CA115883
项目资助者: Purdue University ; National Cancer Institute (NCI)
WOS记录号: WOS:000299121000027
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/64262
Appears in Collections:北京大学医药卫生分析中心_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA
2.Peking Univ, Med Isotopes Res Ctr, Beijing 100083, Peoples R China

Recommended Citation:
Shi, Jiyun,Zhou, Yang,Chakraborty, Sudipta,et al. Evaluation of In-111-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability[J]. THERANOSTICS,2011,1:322-340.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Shi, Jiyun]'s Articles
[Zhou, Yang]'s Articles
[Chakraborty, Sudipta]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Shi, Jiyun]‘s Articles
[Zhou, Yang]‘s Articles
[Chakraborty, Sudipta]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace